Integrated Filing — IndAS



General information about company

Scrip Code 507794
NSE Symbol KHAICHEM
MSEI Symbol NOTLISTED
ISIN INE745B01028
Name of company Khaitan Chemicals & Fertilizers Limited
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2025
Date of end of financial year 31-03-2026
Date of board meeting when results were approved 23-04-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 18-04-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Multi segment
Description of single segment
Start date and time of board meeting 23-04-2026   12:30:00
End date and time of board meeting 23-04-2026   15:31:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public No
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. No
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 23-04-2026
Indicate Company website link for updated RPT policy of the Company https://kcfl.co.in/wp-content/uploads/2022/05/Related-Party-Transactions-Policy.pdf
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
No default has been made.



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-01-2026 01-04-2025
B Date of end of reporting period 31-03-2026 31-03-2026
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
1 Income
Revenue from operations 19,297.45 1,00,162.94
Other income 55.26 150.13
Total income 19,352.71 1,00,313.07
2 Expenses
(a) Cost of materials consumed 12,169.48 62,565.93
(b) Purchases of stock-in-trade 504.57 504.57
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 427.53 972.43
(d) Employee benefit expense 755.69 3,011.51
(e) Finance costs 749.56 3,289.55
(f) Depreciation, depletion and amortisation expense 238.83 987.61
(f) Other Expenses
1 Outward transportation 1,147.65 7,049.59
2 Others 2,528.69 14,759.13
Total other expenses 3,676.34 21,808.72
Total expenses 18,522.00 93,140.32
3 Total profit before exceptional items and tax 830.71 7,172.75
4 Exceptional items 0.00 0.00
5 Total profit before tax 830.71 7,172.75
6 Tax expense
7 Current tax 5.10 5.10
8 Deferred tax 283.22 291.70
9 Total tax expenses 288.32 296.80
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 542.39 6,875.95
12 Profit (loss) from discontinued operations before tax (416.16) (416.16)
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax (416.16) (416.16)
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period 126.23 6,459.79
17 Other comprehensive income net of taxes 342.43 331.08
18 Total Comprehensive Income for the period 468.66 6,790.87
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 969.89 969.89
Face value of equity share capital 1 1
27 Details of debt securities
22 Reserves excluding revaluation reserve 0.00
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 0.56 7.09
Diluted earnings (loss) per share from continuing operations 0.56 7.09
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations -0.43 -0.43
Diluted earnings (loss) per share from discontinued operations -0.43 -0.43
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 0.13 6.66
Diluted earnings (loss) per share from continuing and discontinued operations 0.13 6.66
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2025
Date of end of reporting period 31-03-2026
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 11,495.64
Capital work-in-progress 287.80
Investment property
Goodwill 0.00
Other intangible assets 17.53
Intangible assets under development
Biological assets other than bearer plants
Investments accounted for using equity method
Non-current financial assets
Non-current investments 704.56
Trade receivables, non-current
Loans, non-current 0.00
Other non-current financial assets
1 Other financial assets 387.20
Total of other non-current financial assets 387.20
Total non-current financial assets 1,091.76
Deferred tax assets (net) 397.93
Other non-current assets
1 Right of use of assets 323.47
2 Other non-current assets 232.30
3 Income tax assets (Net) 276.34
Total of other non-current assets 832.11
Total non-current assets 14,122.77
2 Current assets
Inventories 22,343.82
Current financial asset
Current investments 0.00
Trade receivables, current 6,238.45
Cash and cash equivalents 5.91
Bank balance other than cash and cash equivalents 1,371.08
Loans, current 5.27
Other current financial assets
Total of other current financial assets 893.04
Total current financial assets 8,513.75
Current tax assets (net)
Other current assets
1 Other current assets 22,737.51
Total of other current assets 22,737.51
Total current assets 53,595.08
3 Non-current assets classified as held for sale 435.15
4 Regulatory deferral account debit balances and related deferred tax Assets
Total assets 68,153.00
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 969.89
Other equity 28,094.99
Total equity attributable to owners of parent 29,064.88
Non controlling interest
Total equity 29,064.88
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 0.00
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises
Total Trade payable
Other non-current financial liabilities
1 Borrowings 2,355.07
2 Lease liabilities 373.83
Total of other non-current financial liabilities 2,728.90
Total non-current financial liabilities 2,728.90
Provisions, non-current 50.28
Deferred tax liabilities (net) 38.40
Deferred government grants, Non-current
Other non-current liabilities
Total of other non-current liabilities
Total non-current liabilities 2,817.58
Current liabilities
Current financial liabilities
Borrowings, current 27,774.98
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 231.25
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 5,281.90
Total Trade payable 5,513.15
Other current financial liabilities
1 Lease liabilities 78.30
2 Other current financial liabilities 1,744.49
Total of other current financial liabilities 1,822.79
Total current financial liabilities 35,110.92
Other current liabilities 1,134.49
1 Other current liabilities 1,134.49
Total of other current liabilities 1,134.49
Provisions, current 25.11
Current tax liabilities (Net) 0.02
Deferred government grants, Current
Total current liabilities 36,270.54
3 Liabilities directly associated with assets in disposal group classified as held for sale
4 Regulatory deferral account credit balances and related deferred tax liability
Total liabilities 39,088.12
Total equity and liabilites 68,153.00
Disclosure of notes on assets and liabilities



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-01-2026 01-04-2025
Date of end of reporting period 31-03-2026 31-03-2026
Whether results are audited or unaudited Audited Audited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
1 Fertilizers 13,781.55 81,953.22
2 Chemicals & Speciality Chemicals 5,821.74 26,199.50
3 Unallocated (others) 0.00 0.00
Total Segment Revenue 19,603.29 1,08,152.72
Less: Inter segment revenue 250.57 7,839.64
Revenue from operations 19,352.72 1,00,313.08
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
1 Fertilizers 1,036.80 6,350.63
2 Chemicals & Speciality Chemicals 543.47 4,111.67
3 Unallocated (others) 0.00 0.00
Total Profit before tax 1,580.27 10,462.30
i. Finance cost 749.56 3,289.55
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax 830.71 7,172.75
3 (Segment Asset - Segment Liabilities)
Segment Asset
1 Fertilizers 62,125.92 62,125.92
2 Chemicals & Speciality Chemicals 4,633.52 4,633.52
3 Unallocated (others) 1,393.55 1,393.55
Total Segment Asset 68,152.99 68,152.99
Un-allocable Assets 0.00 0.00
Net Segment Asset 68,152.99 68,152.99
4 Segment Liabilities
Segment Liabilities
1 Fertilizers 38,613.42 38,613.42
2 Chemicals & Speciality Chemicals 459.97 459.97
3 Unallocated (others) 14.71 14.71
Total Segment Liabilities 39,088.10 39,088.10
Un-allocable Liabilities 0.00 0.00
Net Segment Liabilities 39,088.10 39,088.10
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-01-2026 01-04-2025
B Date of end of reporting period 31-03-2026 31-03-2026
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Re-measurements gain/(loss) on defined benefit plans (5.31) 22.26
2 Changes in fair value of financial assets 240.89 240.89
Total Amount of items that will not be reclassified to profit and loss 235.58 263.15
2 Income tax relating to items that will not be reclassified to profit or loss 46.99 40.05
3 Amount of items that will be reclassified to profit and loss
1 Gains & (Losses) in Cash Flow Hedges 205.58 144.30
Total Amount of items that will be reclassified to profit and loss 205.58 144.30
4 Income tax relating to items that will be reclassified to profit or loss 51.74 36.32
5 Total Other comprehensive income 342.43 331.08



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2025
B Date of end of reporting period 31-03-2026
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Standalone
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 7,172.75
Adjustments for reconcile profit (loss)
Adjustments for finance costs 2,789.12
Adjustments for decrease (increase) in inventories (1,093.38)
Adjustments for decrease (increase) in trade receivables, current 971.73
Adjustments for decrease (increase) in trade receivables, non-current 0.00
Adjustments for decrease (increase) in other current assets (6,167.87)
Adjustments for decrease (increase) in other non-current assets 0.00
Adjustments for other financial assets, non-current (91.36)
Adjustments for other financial assets, current (518.48)
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current 1,316.83
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities (1,358.83)
Adjustments for increase (decrease) in other non-current liabilities 0.00
Adjustments for depreciation and amortisation expense 987.61
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0.00
Adjustments for provisions, current 29.61
Adjustments for provisions, non-current 0.00
Adjustments for other financial liabilities, current 800.80
Adjustments for other financial liabilities, non-current (150.63)
Adjustments for unrealised foreign exchange losses gains 0.00
Adjustments for dividend income 0.00
Adjustments for interest income 0.00
Adjustments for share-based payments 0.00
Adjustments for fair value losses (gains) 0.00
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow 0.00
Other adjustments to reconcile profit (loss) 0.00
Other adjustments for non-cash items 235.15
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) (2,249.70)
Net cash flows from (used in) operations 4,923.05
Dividends received 0.00
Interest paid 0.00
Interest received (102.64)
Income taxes paid (refund) 393.45
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities 4,426.96
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 0.00
Other cash receipts from sales of equity or debt instruments of other entities 0.00
Other cash payments to acquire equity or debt instruments of other entities 0.00
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 128.00
Purchase of property, plant and equipment 895.68
Proceeds from sales of investment property 0.00
Purchase of investment property 0.00
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 0.00
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 0.00
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 0.00
Purchase of other long-term assets 0.00
Cash advances and loans made to other parties 0.00
Cash receipts from repayment of advances and loans made to other parties 0.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 0.00
Interest received 102.64
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 242.52
Net cash flows from (used in) investing activities (422.52)
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 0.00
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares 0.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 0.00
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 0.00
Repayments of borrowings 1,217.39
Payments of lease liabilities 0.00
Dividends paid 0.00
Interest paid 2,789.11
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) financing activities (4,006.50)
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes (2.06)
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0.00
Net increase (decrease) in cash and cash equivalents (2.06)
Cash and cash equivalents cash flow statement at beginning of period 7.97
Cash and cash equivalents cash flow statement at end of period 5.91





Details of Impact of Audit Qualification

Amount in (Lakhs)

Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 NSBP & CO Yes 30-04-2027


Amount in (Lakhs)

Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)

Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity/subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 KHAITAN CHEMICALS AND FERTILIZERS LIMITED Shradha Projects Limited Significant Influence (With 44.71% Holding) Investment Approved by the board since long 0.00 463.68 704.55
2 KHAITAN CHEMICALS AND FERTILIZERS LIMITED Shradha Projects Limited Significant Influence (With 44.71% Holding) Loan Approved by the board since long 595.00 1,588.00 1,588.00
3 KHAITAN CHEMICALS AND FERTILIZERS LIMITED Shradha Projects Limited Significant Influence (With 44.71% Holding) Interest paid AS APPROVED BY BOARD 52.23 31.58 27.28
4 KHAITAN CHEMICALS AND FERTILIZERS LIMITED Shradha Projects Limited Significant Influence (With 44.71% Holding) Any other transaction RENT Approved by the board since long 1.80 0.00 0.00
5 KHAITAN CHEMICALS AND FERTILIZERS LIMITED Smt. Swapna Khaitan Wife of Chairman & Managing Director Any other transaction RENT Approved by the board since long 71.92 0.30 9.40
6 KHAITAN CHEMICALS AND FERTILIZERS LIMITED Shri Jagdish Lal Jajoo Whole Time Director Remuneration As per policy approved by the Board/Committee from time to time 0.00 0.00 0.00
7 KHAITAN CHEMICALS AND FERTILIZERS LIMITED Shri Harsh Vardhan Agnihotri President & Chief Financial Officer Remuneration As per policy approved by the Board/Committee from time to time 19.76 0.00 0.00
8 KHAITAN CHEMICALS AND FERTILIZERS LIMITED Mrs. Sejal Maheshwari Company Secretary & Compliance Officer Remuneration As per policy approved by the Board/Committee from time to time 4.43 0.00 0.17
9 KHAITAN CHEMICALS AND FERTILIZERS LIMITED Mr. Praveen Uniyal Whole Time Director Remuneration As per policy approved by the Board/Committee from time to time 2.69 0.09 0.23
10 KHAITAN CHEMICALS AND FERTILIZERS LIMITED Shri Inderjit Singh Independent Director Any other transaction Sitting fees Rs. 25000/- per Board Meeting and Rs. 10000/- per Committee Meetings 0.55 0.00 0.00
11 KHAITAN CHEMICALS AND FERTILIZERS LIMITED Shri Deepak Kumar Khemka Independent Director Any other transaction Sitting fees Rs. 25000/- per Board Meeting and Rs. 10000/- per Committee Meetings 1.10 0.00 0.00
12 KHAITAN CHEMICALS AND FERTILIZERS LIMITED Ms. Payal Gupta Independent Women Director Any other transaction Sitting fees Rs. 25000/- per Board Meeting and Rs. 10000/- per Committee Meetings 1.10 0.00 0.00
13 KHAITAN CHEMICALS AND FERTILIZERS LIMITED B O Constructions Private Limited Enterprises which is under significant of KMP and/ or their Relatives Any other transaction RENT Maximum amount of transaction Upto Rs. 2 Crores 8.37 1.33 1.67
14 KHAITAN CHEMICALS AND FERTILIZERS LIMITED The Majestic pacaking Co Private Limited Enterprises which is under significant of KMP and/ or their Relatives Loan Maximum amount of transaction Upto Rs. 20 Crores 0.00 612.00 612.00
15 KHAITAN CHEMICALS AND FERTILIZERS LIMITED The Majestic pacaking Co Private Limited Enterprises which is under significant of KMP and/ or their Relatives Interest paid As approved by board 52.77 27.91 12.22
16 KHAITAN CHEMICALS AND FERTILIZERS LIMITED ARATI MARKETING PVT LTD Enterprises which is under significant of KMP and/ or their Relatives Interest paid As approved by board 9.16 7.88 0.00
Total value of transaction during the reporting period 820.88